Skip to main content
. 2015 Oct 14;6(42):44955–44962. doi: 10.18632/oncotarget.5831

Table 2. Relevant sociological, clinical and pathological characteristics of the entire cohort and patients segregated based on disease stage.

Stage I and II Stage III Stage Unknown P* Total
Median Range Median Range Median Range Median Range
Year of Diagnosis 2005 1988–2012 2006 1988–2012 1998 1988–2012 <0.001 2004 1988–2012
Age at Diagnosis (yr) 53 18–89 54 20–87 52 18–88 0.286 53 18–89
Size in mm 100 12–800 117 12–280 105 1–990 0.157 105 1–990
N and % 332 52 215 33 94 15 641
Sex 0.103
 Male 117 35 92 43 30 32 239 37
 Female 215 65 123 57 64 68 402 63
Race 0.146
 White 279 84 192 89 84 89 555 87
 Other 53 16 23 11 10 11 86 13
Marital status 0.282
 Divorced 23 7 17 8 9 10 49 8
 Married 209 63 142 66 54 57 405 63
 Single 70 21 37 17 18 19 125 20
 Separated 1 3 1 0 0 4 1
 Widowed 25 8 12 6 11 12 48 7
 Unknown 4 1 4 2 2 2 10 2
Laterality 0.063
 Left 193 58 103 48 50 53 346 54
 Right 139 42 108 50 44 47 291 45
 Unknown or bilateral 4 2 4 1
Tumor Grade 0.026**
 I/II 38 11 18 8 13 14 69 11
 III/IV 40 12 43 20 10 11 93 15
 Unknown 254 77 154 72 71 76 479 75
Lymph node examined <0.001
 No 273 82 127 59 88 94 488 76
 Yes 54 16 83 39 2 2 139 22
 Unknown 5 2 5 2 4 4 14 2
Radiotherapy 0.0067
 No or unknown 312 94 185 86 86 91 583 91
 Yes 20 6 30 14 8 9 58 9
Cause of death <0.001
 Alive 186 56 77 36 28 30 291 45
 Dead (due to ACC) 110 33 122 57 51 54 283 44
 Dead (due to other reasons) 36 11 16 7 15 16 67 10
*

compared among stage I/II, stage III and stage Unknown groups using analysis of variance and χ2 test for continuous variables and for categorical variables, respectively.

**

compared among stage I/II, stage III and stage unknown groups using Fisher's exact probability test. Cases with unknown grade were excluded.